Last reviewed · How we verify
NCT05079100
Effectiveness of Counseling on Use of Postpartum Family Planning.
NA trial testing postpartum contraception method counselling in Contraceptive Usage in 120 participants. Completed in 20 May 2022.
1 March 2022
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 120 |
| Start date | 1 February 2022 |
| Primary completion | 1 March 2022 |
| Estimated completion | 20 May 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- postpartum contraception method counselling
Conditions studied
- Contraceptive Usage — all drugs for Contraceptive Usage →
Sponsor
Assiut University
Who can join
Adults 15 to 49, female only, with Contraceptive Usage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Family planning (FP) is the most supported, reasonable public health service to prevent both maternal and newborn mortality and decrease the risk of adverse maternal, perinatal, and infant outcomes. The World Health Organization's (WHO) recommend of waiting at least 2 years after a live birth before attempting the next pregnancy as short interval between pregnancies increase risk of preterm labor; low birth weight; fetal, early neonatal and infant death; and serious maternal outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05079100
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Contraceptive Usage
Currently open trials in the same condition.
- NCT07039591 — Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlan · EARLY_PHASE1 · recruiting
- NCT06682065 — Telemedicine Contraceptive Counselling (TECC) Versus Standard Care · NA · recruiting
- NCT05674513 — Disparities in Emergency Contraceptive Metabolism Dictate Efficacy · Phase 4 · recruiting
- NCT04558229 — RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users · Phase 4 · active not recruiting
- NCT03984695 — Sexual Health Empowerment for Women's Health · NA · active not recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05079100 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 23 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05079100.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing